Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.

Signify Premium Insight: Trends and Takeaways from RSNA 2021 – Medical Imaging Modalities

Signify Premium Insights Subscription Required

15th December 2021 – RSNA 2021 was hotly anticipated by vendors and providers alike. This excitement was rewarded with numerous budding technologies finding their way onto the show floor, most of which were focused upon a singular goal.

Signify Analysts’ Impressions of RSNA

14th December 2021 – After two years, RSNA was back and bristling with innovation from large established vendors and smaller start ups alike. In this Insight, Signify Research’s analysts share their key takeaways from this important conference.

How value-based healthcare is affecting product choice in the anaesthesia and respiratory care markets

14th December 2021 – Value-based care has been prevalent in the US for many years, and more recently several other countries have started to roll out healthcare reform plans that also focus on improving the quality of healthcare provision, whilst increasing efficiency of the care provided.

Signify Premium Insight: Trends and Takeaways from RSNA 2021 – Imaging IT and AI

Signify Premium Insights Subscription Required

10th December 2021 – Despite the challenges of exhibiting at RSNA, and the smaller number of attendees, the response to this year’s RSNA was positive. There were some innovative product launches, but for many imaging IT and AI vendors, the focus was on much more pragmatic developments.

Revenue growth for fixed General Radiography and Fluoroscopy is set to reach 10% and 8% respectively in 2021

9th December 2021 – After a challenging 2020 with COVID-19, Signify Research assesses how the market is set to rebound in 2021 in the General Radiography and Fluoroscopy markets